This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Key Event: 2230
Key Event Title
Increased, afferent artery vasoconstriction
Short name
Biological Context
| Level of Biological Organization |
|---|
| Tissue |
Organ term
| Organ term |
|---|
| kidney |
Event Components
| Process | Object | Action |
|---|---|---|
| vasoconstriction | kidney afferent arteriole smooth muscle cell | increased |
Key Event Overview
AOPs Including This Key Event
| AOP Name | Role of event in AOP | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|
| Activation of PKC leads to Kidney Failure | KeyEvent | Arthur Author (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Life Stages
| Life stage | Evidence |
|---|---|
| All life stages |
Sex Applicability
| Term | Evidence |
|---|---|
| Unspecific | High |
Key Event Description
As blood travels from the aorta into the renal arteries, it divides into smaller vessels known as the afferent arteries, which are intricately involved in kidney-specific blood flow regulation. These arteries play an essential role in governing the amount of blood that enters the kidneys (Eaton, 2009). Further branching of the afferent arteries leads to the Bowman's capsule, specifically the glomerulus, where blood filtration occurs (Terasaki, 2020). This filtration process is essential for removing waste products and regulating electrolyte balance (Dalal, 2024).
The biological significance of afferent arteries extends beyond blood flow regulation. They actively influence vital physiological processes such as blood pressure and the glomerular filtration rate (GFR) (Dalal, 2023). By adjusting their diameter, these arteries modulate the pressure within the glomeruli, thus impacting the rate at which blood is filtered in the kidneys (Gohar, 2019).
Vasoconstriction, a phenomenon characterized by the narrowing of blood vessels, profoundly influencing vascular function (NIH, 2023). This physiological process, governed by small muscles within the vessel walls, is subject to various factors including medications, medical conditions, stress, and smoking (Cleveland Clinic Medical, 2024). Hormones such as angiotensin II, and norepinephrine intricately regulate vasoconstriction (Wilson, 1896).
How It Is Measured or Detected
Vasoconstriction of the afferent arteries, a crucial aspect of renal hemodynamics, can be indirectly assessed through the measurement of renal blood flow (RBF) or the glomerular filtration rate (GFR) (Feher, 2017).
Renal blood flow can be noninvasively evaluated using various techniques, including contrast-enhanced ultrasound, positron emission tomography (PET), magnetic resonance imaging (MRI), and computerized tomography (CT) (Thurman & Gueler, 2018). Traditional methods utilize radioisotopes or clearance methods with substances like para-aminohippurate (Moraitis, 2024). Enhanced vasoconstriction typically results in a decrease in RBF (Dalal, 2023).
Similarly, GFR, a key indicator of renal function, can be directly measured using exogenous filtration markers like inulin and iohexol, or indirectly estimated through endogenous markers such as serum creatinine and cystatin C (Thompson, 2022). Indirect measurement, often via urine sample collection over time, is more common due to its non-invasiveness. Radioisotope techniques are also available for GFR assessment (LaFrance, 1988). Increased vasoconstriction generally leads to a reduction in GFR (Dalal, 2023).
These methods collectively provide valuable insights into the impact of afferent artery vasoconstriction on renal function, aiding in the diagnosis and management of renal disorders.
Domain of Applicability
Taxonomic Applicability: The key event applies to vertebrates. Afferent arterioles are a kidney specific biological structure, and therefore specific to vertebrates since kidneys are vertebrate specific.
Life Stage Applicability: The key event is not life stage specific. Vasoconstriction of the afferent arterioles can happen at any age; therefore, the KE is not life stage specific. Age may have an influence on the integrity of the arterioles however, the KE can occur regardless.
Sex Applicability: The key event is not sex specific. Afferent arterioles are not a sex specific biological structure in the kidneys. There is no significant influence on vasoconstriction reactivity to endothelin receptor activation between the sexes (Gohar, 2019).
References
Cleveland Clinic Medical. (2024). Vasoconstriction: What is it, symptoms, causes & treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/symptoms/21697-vasoconstriction
Dalal, R., Bruss, Z.S, Sehdev, J.S. Physiology, Renal Blood Flow and Filtration. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482248/
Eaton, D. C., & Pooler, J. (2009). Vander’s Renal Physiology. McGraw-Hill Education.
Feher, J. J. (2017). Quantitative human physiology: An introduction. Academic Press.
Gohar, E. Y., Cook, A. K., Pollock, D. M., & Inscho, E. W. (2019). Afferent arteriole responsiveness to endothelin receptor activation: does sex matter?. Biology of sex differences, 10(1), 1. https://doi.org/10.1186/s13293-018-0218-2
LaFrance, N. D., Drew, H. H., & Walser, M. (1988). Radioisotopic measurement of glomerular filtration rate in severe chronic renal failure. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 29(12), 1927–1930.
Moraitis, A., Jentzen, W., Fragoso Costa, P., Kersting, D., Himmen, S., Coelho, M., Meckel, M., van Echteld, C. J. A., Fendler, W. P., Herrmann, K., & Sraieb, M. (2024). Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 65(6), 931–937. https://doi.org/10.2967/jnumed.123.266619
NIH (2023). Vasoconstriction: MedlinePlus medical encyclopedia. MedlinePlus. https://medlineplus.gov/ency/article/002338.htm#:~:text=Vasoconstriction%20is%20the%20narrowing%20(constriction,%2C%20medicines%2C%20or%20psychological%20conditions
Terasaki, M., Brunson, J. C., & Sardi, J. (2020). Analysis of the three-dimensional structure of the kidney glomerulus capillary network. Scientific reports, 10(1), 20334. https://doi.org/10.1038/s41598-020-77211-x
Thompson, L. E., & Joy, M. S. (2022). Endogenous markers of kidney function and renal drug clearance processes of filtration, secretion, and reabsorption. Current opinion in toxicology, 31, 100344. https://doi.org/10.1016/j.cotox.2022.03.005
Thurman, J., & Gueler, F. (2018). Recent advances in renal imaging. F1000Research, 7, F1000 Faculty Rev-1867. https://doi.org/10.12688/f1000research.16188.1
Wilson S. K. (1986). The effects of angiotensin II and norepinephrine on afferent arterioles in the rat. Kidney international, 30(6), 895–905. https://doi.org/10.1038/ki.1986.270